US2007196370A1PendingUtilityA1
Type 2 cytokine receptor and nucleic acids encoding same
Est. expiryJan 12, 2021(expired)· nominal 20-yr term from priority
A61P 43/00A61P 9/00A61P 35/00A61P 37/06A61P 37/02A61P 25/00A61P 29/00A61K 38/00A61K 2039/53A61K 2039/505C07K 2319/00A61P 19/02C07K 14/715
47
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides novel isolated CRF2-12 polynucleotides and polypeptides encoded by the CRF2-12 polynucleotides. Also provided are the antibodies that immunospecifically bind to a CRF2-12 polypeptide or any derivative (including fusion derivative), variant, mutant or fragment of the CRF2-12 polypeptide, polynucleotide or antibody. The invention additionally provides methods in which the CRF2-12 polypeptide, polynucleotide and antibody are utilized in the detection and treatment of a broad range of pathological states, as well as to other uses.
Claims
exact text as granted — not AI-modified1 . An isolated nucleic acid molecule encoding a polypeptide comprising amino acids 21-66 of SEQ ID NO:2, or the complement of said nucleic acid molecule.
2 - 64 . (canceled)Join the waitlist — get patent alerts
Track US2007196370A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.